Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
Institut du Cancer de Montpellier - Val d'Aurelle
Institut du Cancer de Montpellier - Val d'Aurelle
Novartis
Bristol-Myers Squibb
Jazz Pharmaceuticals
NuCana plc
Ludwig-Maximilians - University of Munich
Pierre Fabre Medicament
Memorial Sloan Kettering Cancer Center
Gruppo Oncologico Italiano di Ricerca Clinica
Ohio State University Comprehensive Cancer Center
Gruppo Oncologico del Nord-Ovest
Ohio State University Comprehensive Cancer Center
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Vejle Hospital
NSABP Foundation Inc
Pfizer
Sumitomo Pharma America, Inc.
National Institutes of Health Clinical Center (CC)
Canadian Cancer Trials Group
Eastern Cooperative Oncology Group
Cantargia AB
Eastern Cooperative Oncology Group
AIO-Studien-gGmbH
Barbara Ann Karmanos Cancer Institute
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
National Cancer Institute, Naples
Gruppo Oncologico del Nord-Ovest
Ludwig Institute for Cancer Research
Incyte Corporation
Sumitomo Pharma Co., Ltd.
National Cancer Institute, Naples
UNICANCER
SCRI Development Innovations, LLC
Kaohsiung Medical University Chung-Ho Memorial Hospital
NSABP Foundation Inc
Medical Research Council
Medical Research Council
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Grupo Espanol Multidisciplinario del Cancer Digestivo
UNICANCER
UNICANCER
UNICANCER
UNICANCER
AryoGen Pharmed Co.
UNC Lineberger Comprehensive Cancer Center
Federation Francophone de Cancerologie Digestive
Odense University Hospital
Isofol Medical AB
Eli Lilly and Company